Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹1,519.35Prev. Close
₹1,524.05Turnover(Lac.)
₹16,276.72Day's High
₹1,536.25Day's Low
₹1,498.352 Week's High
₹1,638.8552 Week's Low
₹1,028.75Book Value
₹110.89Face Value
₹1Mkt Cap (₹ Cr.)
3,68,045.99P/E
120.96EPS
12.67Divi. Yield
0.8831 Jan 2024
12:00 AM
Dividend
Dividend Amount: 8.5
Record Date: 09 Feb, 2024
7 Jul 2023
12:00 AM
AGM
Announcement Date: 07 Jul, 2023
13 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 239.93 | 239.93 | 239.93 | 239.93 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 23,508.43 | 24,348.02 | 26,698.54 | 24,156.29 |
Net Worth | 23,748.36 | 24,587.95 | 26,938.47 | 24,396.22 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 15,585.98 | 14,116.05 | 12,531.93 | 7,923.84 |
yoy growth (%) | 10.41 | 12.64 | 58.15 | 3.12 |
Raw materials | -5,650.39 | -5,107.48 | -4,567.72 | -3,492.77 |
As % of sales | 36.25 | 36.18 | 36.44 | 44.07 |
Employee costs | -2,000.78 | -1,805.98 | -1,702.77 | -1,617.69 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 2,127.39 | 945.13 | 3,253 | 430.52 |
Depreciation | -1,349.95 | -1,236.43 | -561.56 | -432.23 |
Tax paid | -406.85 | -13.17 | -41.86 | 25.39 |
Working capital | -5,179.41 | -888.49 | 3,200.15 | 1,619.85 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 10.41 | 12.64 | 58.15 | 3.12 |
Op profit growth | 28.82 | -16.76 | 2,104.23 | 7.94 |
EBIT growth | 107.43 | -66.87 | 347.1 | 296.01 |
Net profit growth | -111.86 | -73.76 | -749.25 | 2,065.45 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 47,758.45 | 43,278.87 | 38,426.42 | 33,233.08 | 32,325.17 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 47,758.45 | 43,278.87 | 38,426.42 | 33,233.08 | 32,325.17 |
Other Operating Income | 738.4 | 606.81 | 228.07 | 265.06 | 512.33 |
Other Income | 1,354.19 | 634.52 | 921.51 | 835.52 | 635.98 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,525.25 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,561.05 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,484.1 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,092.55 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,492.3 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Dilip S Shanghvi
Non-Exec & Non-Independent Dir
Sudhir V Valia
Whole-time Director
Sailesh T Desai
Non-Exec. & Independent Dir.
Gautam Doshi
Lead Independent Director
Pawan Goenka
Independent Director
Rama Bijapurkar
Company Sec. & Compli. Officer
Anoop Deshpande
Independent Director
Sanjay K Asher
Independent Director
Rolf Hoffmann
Whole Time Director
Aalok Shanghvi
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Sun Pharmaceuticals Industries Ltd
Summary
Sun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates. The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, orthopaedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals.The company has global presence with 43 manufacturing facilities across the world. India and the US are two predominant markets, accounting for nearly 70% of the companys revenue. The company has a robust product pipeline and established presence in Europe and high-growth emerging markets like Russia, Romania, South Africa, Brazil a
Read More
What is the Sun Pharmaceuticals Industries Ltd share price today?
The Sun Pharmaceuticals Industries Ltd shares price on nse is Rs.₹1533.95 today.
What is the Market Cap of Sun Pharmaceuticals Industries Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sun Pharmaceuticals Industries Ltd is ₹368045.99 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Sun Pharmaceuticals Industries Ltd?
The PE and PB ratios of Sun Pharmaceuticals Industries Ltd is 120.96 and 15.52 as of 03 Jul ‘24
What is the 52 Week High and Low of Sun Pharmaceuticals Industries Ltd?
The 52-week high/low is the highest and lowest price at which a Sun Pharmaceuticals Industries Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Sun Pharmaceuticals Industries Ltd is ₹1028.75 and ₹1638.85 as of 03 Jul ‘24
What is the CAGR of Sun Pharmaceuticals Industries Ltd?
Sun Pharmaceuticals Industries Ltd's CAGR for 5 Years at 30.97%, 3 Years at 30.79%, 1 Year at 47.58%, 6 Month at 17.58%, 3 Month at -6.05% and 1 Month at 4.89%.
What is the shareholding pattern of Sun Pharmaceuticals Industries Ltd?
The shareholding pattern of Sun Pharmaceuticals Industries Ltd is as follows:
Promoters - 54.48 %
Institutions - 36.55 %
Public - 8.97 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
